BSEInsider Trading / SASTRegulatory4 Sept 2026
Manipal Health Enterprises Ltd
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on September ....
Manipal Health Enterprises Ltd has made a disclosure under SEBI (SAST) Regulations, 2011, regarding reasons for encumbrance by its promoter.
BSEInsider Trading / SASTPromoter Reclassif.4 Sept 2026
Manipal Health Enterprises Ltd
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 03, 2026 for Manipal Global ....
Manipal Health Enterprises Ltd has made a disclosure under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, indicating a potential change in promoter shareholding.
BSECompany Update3 Sept 2026
Manipal Health Enterprises Ltd
Newspaper Publication - Information regarding 16th Annual General Meeting
Manipal Health Enterprises Ltd has announced the publication of information regarding its 16th Annual General Meeting, which will be held through video conference on September 29, 2026.
BSECompany Update▲ PositiveResults27 Aug 2026
Manipal Health Enterprises Ltd
Transcript of the Earnings call with Analysts/ Investors
Manipal Health Enterprises Ltd reported Q1 FY27 earnings with revenue of INR3,091 crores, a 38% YoY growth, and EBITDA of INR749 crores, a 26% YoY growth. The company saw volume-led growth, with inpatient volumes up 39% and OP volumes up 26% YoY. Digital revenue grew significantly, contributing 23% to overall revenue.
BSECompany UpdateResults21 Aug 2026
Manipal Health Enterprises Ltd
Audio recording of the Earnings call with Analysts/Investor
Manipal Health Enterprises Ltd has uploaded the audio recording of its earnings call with analysts/investors on its website, as per SEBI listing regulations.
BSECompany UpdateResults21 Aug 2026
Manipal Health Enterprises Ltd
Newspaper extract of the Un-audited Financial Results of the Company for the Quarter June 30, 2026.
Manipal Health Enterprises Ltd has announced its un-audited financial results for the quarter ended June 30, 2026, with the results being published in the newspapers Business Standard and Vishwavani on August 21, 2026.
BSECompany UpdateMgmt Change20 Aug 2026
Manipal Health Enterprises Ltd
Announcement under Regulation 30 (LODR) - Change in Management
Manipal Health Enterprises Ltd has announced changes in its management, including the appointment of new statutory auditors, re-appointment of directors, and amendment to its Articles of Association. The company has also announced the convening of its 16th Annual General Meeting on September 29, 2026.
BSECompany UpdateMgmt Change20 Aug 2026
Manipal Health Enterprises Ltd
Intimation for appointment of Statutory Auditors
Manipal Health Enterprises Ltd has announced the appointment of M/s Price Waterhouse Chartered Accountants LLP as its Statutory Auditors for a term of 5 years, re-appointment of Dr. Hebri Sudarshan Ballal and Mr. Puneet Bhatia as Directors, and convening of the 16th Annual General Meeting on September 29, 2026.
BSECompany Update▲ PositiveResults20 Aug 2026
Manipal Health Enterprises Ltd
Press release and Investor Presentation for the Earnings Conference Call with Analysts and Investors of Manipal Health Enterprises Limited (the "Company").
Manipal Health Enterprises Ltd announced its Q1 FY27 financial results, with revenue from operations at ₹ 3,091 crore, registering 38.1% year-on-year growth, and EBITDA at ₹ 749 crore, reflecting year-on-year growth of 26.4%. The company delivered a strong operating performance during the quarter, supported by sustained patient demand, growth in high-acuity specialties, and capacity absorption.
BSECompany Update▲ PositiveResults20 Aug 2026
Manipal Health Enterprises Ltd
Press release and Investor Presentation for the Earnings Conference Call with Analysts and Investors.
Manipal Health Enterprises Ltd announced its financial results for Q1 FY27, with revenue from operations standing at ₹ 3,091 crore, registering 38.1% year-on-year growth, and EBITDA standing at ₹ 749 crore, reflecting year-on-year growth of 26.4%. The company delivered a strong operating performance during the quarter, supported by sustained patient demand, growth in high-acuity specialties, and capacity absorption.
BSEResultResults20 Aug 2026
Manipal Health Enterprises Ltd
Board meeting outcome for the Board meeting held on August 20, 2026
Manipal Health Enterprises Ltd has announced the outcome of its board meeting held on August 20, 2026, where it approved unaudited financial results for the quarter ended June 30, 2026, and other matters including the appointment of a new auditor, re-appointment of directors, and convening of the 16th Annual General Meeting.
BSEBoard MeetingResults20 Aug 2026
Manipal Health Enterprises Ltd
Board Meeting Outcome for the meeting held on August 20, 2026 For Declaration Of Unaudited Financial Results For The Quarter Ended June 30, 2026.
The Board of Directors of Manipal Health Enterprises Ltd has approved unaudited financial results for the quarter ended June 30, 2026, and other matters including the appointment of new statutory auditors, re-appointment of directors, and amendment to the Articles of Association.
BSECompany Update▲ PositiveExpansion18 Aug 2026
Manipal Health Enterprises Ltd
Press release titled " Manipal Health Enterprises to Acquire Kinder Women''s Hospital in Bengaluru".
Manipal Health Enterprises Ltd has announced the acquisition of Kinder Women's Hospital in Bengaluru for a cash consideration of INR 130 Crores. The acquisition will expand Manipal Hospitals' presence in Bengaluru's fast-growing Whitefield micro-market and add 100 additional beds to its pan-India capacity.
BSECompany UpdateM&A17 Aug 2026
Manipal Health Enterprises Ltd
Intimation for executing Business Transfer Agreement with Kindorama Healthcare Private Limited.
Manipal Health Enterprises Ltd has signed a Business Transfer Agreement with Kindorama Healthcare Private Limited to acquire the entire operations of Kinder Women's Hospital and Fertility Centre in Bengaluru, Karnataka. The acquisition is subject to completion of conditions precedents and is expected to be completed within 90 days. The consideration for the acquisition is INR 130,00,00,000 (Indian Rupees One Hundred and Thirty Crores) for asset acquisition.
BSECompany UpdateResults17 Aug 2026
Manipal Health Enterprises Ltd
As per attached letter
Manipal Health Enterprises Ltd has scheduled an earnings conference call to discuss Q1 FY 2026-27 financial performance on August 21, 2026.
BSEInsider Trading / SASTPledge14 Aug 2026
Manipal Health Enterprises Ltd
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on August ....
Manipal Health Enterprises Ltd has disclosed reasons for encumbrance by its promoters under SEBI (SAST) Regulations, 2011, including non-disposal undertakings and pledges over shares of the company and its promoter group entities.
BSEInsider Trading / SASTPledge14 Aug 2026
Manipal Health Enterprises Ltd
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 14, 2026 for Manipal Global Health ....
Manipal Health Enterprises Ltd has disclosed under Regulation 31(1) and 31(2) of SEBI (SAST) Regulations, 2011, that certain promoters and promoter group entities have created pledges over shares of the company.
BSEBoard MeetingResults14 Aug 2026
Manipal Health Enterprises Ltd
Manipal Health Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/08/2026 ,inter alia, to consider and approve the unaudited financial ....
Manipal Health Enterprises Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 20/08/2026 to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
BSEInsider Trading / SASTPledge10 Aug 2026
Manipal Health Enterprises Ltd
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vistra ITCL (India) Ltd
Manipal Health Enterprises Ltd has received a disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, regarding the pledge and encumbrance of its equity shares by Vistra ITCL (India) Ltd to secure non-convertible debentures aggregating up to INR 65,500,00,000.
BSEInsider Trading / SASTRegulatory10 Aug 2026
Manipal Health Enterprises Ltd
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Deutsche Bank AG
Deutsche Bank AG, Singapore Branch discloses creation of indirect encumbrances over equity shares of Manipal Health Enterprises Limited, as part of a term loan facility.